Finished
Robotic and Laparoscopic Total Gastrectomy With D2 Lymphadenectomy for Locally Advanced Gastric Cancer
NCT03500471 · Southwest Hospital, China · Updated 21 Oct 2021
- What is being tested
- Robotic-assisted Total Gastrectomy; Laparoscopic-assisted Total Gastrectomy
- For
- Gastric Cancer
- Kind of study
- Watches patients without assigning a treatment. No drug phase (a device or procedure study).
- Who can join
- Ages 18 years to 80 years. About 142 people. The full rules are on the registry page.
- Where
- China
- When
- Starts or started 16 April 2018, ends 30 Aug 2021. Registered 18 April 2018.
- Results
- None posted yet.
In the researchers' words
This study is a prospective, single-center, non-randomized, controlled, non-blind, and non-inferiority observation trial comparing robotic-assisted total gastrectomy with D2 lymph nodal dissection for locally advanced gastric cancer patients with laparoscopic procedure.
Sites
- Department of General Surgery and Center of Microinvasive Gastrointestinal Surgery,Southwest HospitalChongqing, Chongqing Municipality, China